Journal of acquired immune deficiency syndromes (1999), 2019-07, Vol.81 (3), p.e94-e98
2019
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Baseline Characteristics Explain Differences in Effectiveness of Randomization to Daily Oral TDF/FTC PrEP Between Transgender Women and Cisgender Men Who Have Sex With Men in the iPrEx Trial
- Ist Teil von
- Journal of acquired immune deficiency syndromes (1999), 2019-07, Vol.81 (3), p.e94-e98
- Ort / Verlag
- United States
- Erscheinungsjahr
- 2019
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1525-4135eISSN: 1944-7884DOI: 10.1097/QAI.0000000000002037Titel-ID: cdi_crossref_primary_10_1097_QAI_0000000000002037
- Format
- –
- Schlagworte
- Adult, Anti-HIV Agents - administration & dosage, Anti-HIV Agents - therapeutic use, Antiretroviral Therapy, Highly Active, Emtricitabine - administration & dosage, Emtricitabine - therapeutic use, Female, HIV Infections - epidemiology, HIV Infections - prevention & control, Humans, Male, Pre-Exposure Prophylaxis - methods, Sex Factors, Tenofovir - administration & dosage, Tenofovir - therapeutic use, Transgender Persons, Treatment Outcome